Related Experiment Video
Updated: Aug 19, 2026

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor
1Department of Medicinal Chemistry, Boehringer Ingelheim Pharma KG, Biberach, Germany. herbert.nar@bc.boehringer-ingelheim.com
Abstract:
Human macrophage elastase (MMP-12) is a member of the family of matrix metalloproteinases (MMPs) that plays, like other members of the family, an important role in inflammatory processes contributing to tissue remodelling and destruction. In particular, a prominent role of MMP-12 in the destruction of elastin in the lung alveolar wall and the pathogenesis of emphysema has been suggested. It is therefore an attractive therapeutic target. We describe here the crystal structure of the catalytic domain of MMP-12 in complex with a hydroxamic acid inhibitor, CGS27023A. MMP-12 adopts the typical MMP fold and binds a structural zinc ion and three calcium ions in addition to the catalytic zinc ion. The enzyme structure shows an ordered N terminus close to the active site that is identical in conformation with the superactivated form of MMP-8. The S1'-specificity pocket is large and extends into a channel through the protein, which puts MMP-12 into the class of MMPs 3, 8 and 13 with large and open specificity pockets. The two crystallographically independent molecules adopt different conformations of the S1'-loop and its neighbouring loop due to differing crystal packing environments, suggesting that flexibility or the possibility of structural adjustments of these loop segments are intrinsic features of the MMP-12 structure and probably a common feature for all MMPs. The inhibitor binds in a bidentate fashion to the catalytic zinc ion. Its polar groups form hydrogen bonds in a substrate-like manner with beta-strand sIV of the enzyme, while the hydrophobic substituents are either positioned on the protein surface and are solvent-exposed or fill the upper part of the specificity pocket. The present structure enables us to aid the design of potent and selective inhibitors for MMP-12.
Insights
The crystal structure of human macrophage elastase (MMP-12) complexed with an inhibitor reveals its active site. This structural insight aids in designing targeted therapies for emphysema and other inflammatory lung diseases.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Human macrophage elastase (MMP-12) is implicated in inflammatory processes, tissue remodeling, and particularly in the pathogenesis of emphysema.
- Its role in elastin destruction within the lung alveolar wall makes MMP-12 a significant therapeutic target.
Purpose of the Study:
- To determine the crystal structure of the catalytic domain of MMP-12.
- To elucidate the binding mode of the hydroxamic acid inhibitor CGS27023A.
- To provide a structural basis for the design of potent and selective MMP-12 inhibitors.
Main Methods:
- X-ray crystallography was used to determine the structure of MMP-12 in complex with CGS27023A.
- Analysis of the enzyme-inhibitor interactions and the active site architecture.
Main Results:
- The crystal structure reveals the typical matrix metalloproteinase fold with bound zinc and calcium ions.
- MMP-12 possesses a large S1'-specificity pocket, similar to MMP-3, MMP-8, and MMP-13.
- The inhibitor CGS27023A binds bidentately to the catalytic zinc ion, forming hydrogen bonds and occupying the specificity pocket.
Conclusions:
- The determined structure provides crucial insights into MMP-12's active site and substrate-binding characteristics.
- Understanding the enzyme's structural features, including loop flexibility, facilitates the rational design of novel therapeutic agents.
- This work supports the development of targeted inhibitors for treating MMP-12-related diseases like emphysema.
Related Concept Videos
Enzyme Inhibition
Role of Matrix Metalloproteases in Degradation of ECM
A...

